Oncothyreon Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ONTY 1.15 -0.04 (-3.36%)
price chart
Oncothyreon Inc (USA) Plunges on Confusing Data
What: Oncothyreon (NASDAQ:ONTY) is down 30% at 1:30 p.m. EST after announcing updated data from its ongoing trials testing ONT-380 in patients with breast cancer yesterday.
Stock Update (NASDAQ:ONTY): Oncothyreon Inc (USA) Reports Third Quarter 2015 ...
Net loss for the three months ended September 30, 2015 was $4.6 million, or $0.05 per basic and diluted share, compared with a net loss of $6.7 million, or $0.09 per basic and diluted share, for the comparable period in 2014.
Analysts Weigh In on Two Falling Stocks: Oncothyreon Inc (USA) (ONTY ...
Analysts weigh in on the biotech company Oncothyreon Inc (USA) (NASDAQ:ONTY) and yoga apparel giant Lululemon Athletica inc.
Biotech Beat: Cantor Weighs In On Oncothyreon Inc (USA) (ONTY) and Galena ...
Cantor analyst Mara Goldstein weighed in today on the cancer therapeutics company Oncothyreon Inc (USA) (NASDAQ:ONTY) and biotech company Galena Biopharma Inc (NASDAQ:GALE), with neutral ratings.
Company Update (NASDAQ:ONTY): Oncothyreon Inc (USA) to Present Updated Data on ...
onty Oncothyreon Inc (USA) (NASDAQ:ONTY), a clinical-stage biopharmaceutical company dedicated to the development of oncology products that can improve the lives and outcomes of patients, today announced that data from the company's ongoing trials ...
Takeways from ASCO 2015: Innate Pharma SA, Oncothyreon Inc (USA), and Affimed NV
Oncothyreon Inc (USA) (NASDAQ:ONTY) continues to be the biggest benefactor of ASCO this year, now up over 200% since investors had a first glimpse at abstracts from the conference.
Why Shares of Oncothyreon Inc. Shot Up Today  Motley Fool
Oncothyreon (ONTY) Stock | When Will We See A Breakout?  CNA Finance (press release)
Here's Why Oncothyreon Inc (USA) Shares Are Fully Valued: Cantor
Oncothyreon Inc (USA) (NASDAQ:ONTY) shares have taken off, adding 24.56% to trade at $4.26, after the biotechnology company presented positive study data for its breast cancer treatment at the American Society of Clinical Oncology 2015 meeting.
Biotech Stocks to Love: Oncothyreon Inc (USA) (NASDAQ:ONTY), Array Biopharma ...
Many individual investors have opted to invest in biotech ETFs and mutual funds. The XBI and SBIO funds have performed well because they focus more on small and mid-sized biotech companies.
Biotech Stocks: Here's Where to Get In- Oncothyreon Inc (USA) (NASDAQ:ONTY ...
However, biotech stocks bucked the trend, continuing to make strong inroads. On the trading floor, shares of Oncothyreon Inc (USA) (NASDAQ:ONTY) gained 4.43% to close at $3.77. The $357.81M company on August 6, 2015 reported financial results for the ...
Biotech Stocks with Pessimistic Trend: Oncothyreon Inc (USA) (NASDAQ:ONTY ...
On the trading floor, shares of Oncothyreon Inc (USA) (NASDAQ:ONTY) dropped 3.66% to close at $2.77. The $281.63M company on August 6, 2015 eported financial results for the second quarter ended June 30, 2015.